Advanced Filters
noise

Junggu, Korea, Republic of Clinical Trials

A listing of Junggu, Korea, Republic of clinical trials actively recruiting patients volunteers.

Found 1,135 clinical trials
J Jaeyoung Cho, M.D., Ph.D.

OSA in Never Smokers With Lung Cancer

Previous studies have yielded inconsistent findings regarding the association between obstructive sleep apnea and the prevalence and mortality of lung cancer. Smoking history, a common risk factor for lung cancer, chronic obstructive pulmonary disease, and obstructive sleep apnea, may act as a confounding variable, limiting interpretation of the results. The …

19 - 80 years of age All Phase N/A
S Seokjin Kim, MD.Phd

Prospective Cohort for Adult Hemophagocytosis

This prospective study enrolls subjects who have clinical and laboratory manifestations related with hemophagocytic lymphohistiocytosis. The purpose of the study is to evaluate clinical and biological features of adult hemophagocytic lymphohistiocytosis. The enrolled subjects into this study will be evaluated according to the HLH (hemophagocytic lymphohistiocytosis)criteria and treated with systemic …

18 - 80 years of age All Phase N/A
S Sodam Jung, MD

Relationship Between Coronary Angiography Findings and Fractional Flow Reserve After Balloon Angioplasty

The goal of this prospective observational study is to learn about in patients who need percutaneous coronary intervention for coronary artery disease. The main questions it aims to answer are: Fractional flow reserve according to coronary angiography findings after coronary artery balloon angioplasty Differences in fractional blood flow reserve before …

19 - 120 years of age All Phase N/A
C Chan-seok Yoon, Dr.

An Observational Study on Postoperative Symptoms After Thyroidectomy (POS-T)

This observational study aimed to evaluate the safety and efficacy of postoperative management in patients with thyroid cancer who received subtotal or total thyroidectomy.

19 years of age All Phase N/A
K Ki Hong Choi, MD

Distribution and Clinical Implication of CMD in Patients With HFpEF Without Significant CAD

To evaluate the incidence of coronary microvascular dysfunction (CMD) and its' prognostic implication in patients who have diagnosed as heart failure with preserved ejection fraction (HFpEF) confirmed by HFA-PEFF scoring system without functionally significant coronary artery disease.

19 years of age All Phase N/A
J Jee Youn Moon, M.D.

Spatially Transcriptomics Reveals Molecular Signatures in CRPS

This observational study aims to understand phenotype-specific molecular signatures in patients with complex regional pain syndrome (CRPS).

19 - 80 years of age All Phase N/A
h hyeokjun choi

Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean Patients

The objective of this post-marketing surveillance (PMS) study is to assess the safety and effectiveness of CRYSVITA injection 10, 20, and 30mg, equivalent to in routine clinical settings

1 years of age All Phase N/A
K Kwon Joong Na, MD

Lung Cancer Surgery in Sarcopenia Patients With Old Age

The presence of sarcopenia before lung resection surgery might be an important factor of short-term and long-term prognosis in lung cancer patients. Through this study, investigators plan to demonstrate evidence whether sarcopenia is a useful clinical biomarker for risk stratification in elderly patients undergoing lung cancer surgery.

70 years of age All Phase N/A
H Haeyoung Kim, MD, PhD

Prospective Cohort for Tumor Bed Boost Radiotherapy in HER2 Positive Breast Cancer

The purpose of this study is to analyze treatment outcomes related to tumor bed boost of postoperative radiation therapy in patient with HER2+ breast cancer who underwent breast conserving surgery. The main questions it aims to answer are: 7-year ipsilateral breast tumor recurrence 7-year disease-free survival 7-year locoregional recurrence 7-year …

19 years of age Female Phase N/A

Korean Regulatory Post Marketing Surveillance for Somavert

Non-interventional observational study, to identify safety and effectiveness of Somavert during the post-marketing period based on the Korean RMP as required by the regulations of Ministry of Food and Drug Safety (MFDS)

18 years of age All Phase N/A

Simplify language using AI